Daniela Thoene

Sanofi, Germany, Germany

Poster(s):

• (B-106) Adherence to risk minimization measures for alemtuzumab use in Multiple Sclerosis: a drug utilisation study in four European countries
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET